Target intelligence / Profile preview

Liver cytochrome P450 enzyme (CYP)

Target
CYP
Molecular classification
Enzyme, Hemoprotein, Monooxygenase, Cytochrome superfamily
01

Overview

Liver cytochrome P450 enzymes are a superfamily of hemoprotein monooxygenases predominantly expressed in the liver, responsible for the oxidative metabolism of a vast array of endogenous and exogenous substrates. They function to hydroxylate, oxidize, and conjugate steroids, fatty acids, xenobiotics, and drugs, facilitating their solubilization and excretion. These enzymes are critical for drug detoxification, metabolism, and elimination, and are divided into multiple families based on sequence similarities (e.g., CYP1, CYP2, CYP3, with key isoforms such as CYP3A4, CYP2D6, CYP1A2, CYP2C9, CYP2C19, and CYP2E1). Their actions underlie significant variability in drug response and potential for drug-drug interactions, as drugs may act as substrates, inhibitors, or inducers of specific CYP450 isoforms. Genetic polymorphisms in CYP genes are a major source of inter-individual variability in drug metabolism. As central mediators in drug metabolism, CYP enzymes are key pharmacological targets, and understanding their activity is essential for safe and effective drug therapy.

Other names
Cytochrome P450CYP450CYP enzymesCYP3A4CYP2D6CYP1A2CYP2C9CYP2C19CYP2E1Microsomal monooxygenases
02

Mechanism of action

Substrate (metabolized by CYP) Inhibitor (blocks CYP activity, increasing plasma drug levels) Inducer (stimulates CYP expression/activity, leading to faster metabolism) Activator (rare; enhances CYP activity)

03

Biological functions

Drug metabolismXenobiotic metabolismSteroid biosynthesis and metabolismFatty acid metabolismEndogenous compound detoxificationRegulation of metabolic homeostasisHydroxylationEpoxidationN/S-oxidationDemethylation/dealkylation
04

Disease associations

CancerInflammationCardiovascular diseaseInfectionPharmacogenomic implicationsLiver disease
05

Safety considerations

Drug-drug interactions (due to shared CYP isoforms for metabolism)Variable drug metabolism due to genetic polymorphisms (pharmacogenomics)Potential for drug toxicity or reduced efficacyFirst-pass metabolism affecting oral drug bioavailabilityInducers/inhibitors impacting the efficacy or safety of co-administered drugsIdiosyncratic hepatotoxicity
06

Interacting drugs

Statins (e.g., simvastatin, atorvastatin)

7 more in the full profile.

07

Biomarkers

CYP genotype/phenotype (e.g., poor, intermediate, extensive metabolizers)CYP3A4/5 activity assaysExpression levels of specific isoforms in tissue analysisDrug plasma level monitoring for drugs metabolized by CYPs

Beyond the preview

Go deeper on Liver cytochrome P450 enzyme (CYP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Liver cytochrome P450 enzyme (CYP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call